Lotus Pharmaceutical's (TPE:1795) will acquire a $70 million receivable from its Singapore subsidiary, Lotus International, as part of the subsidiary's capital reduction.
The receivable is due from Lotus Investment, also a subsidiary of the company.
The transaction will be carried out by offsetting Lotus International's capital return against the receivable, which will then be assigned to Lotus Pharmaceutical.
The transaction forms part of the group's capital utilization planning, the company said.